Related Articles
Functional advantage of NPC-related V-val subtype of Epstein-Barr virus nuclear antigen 1 compared with prototype in epithelial cell line
The V-val subtype Epstein-Barr virus nuclear antigen 1 promotes cell survival after serum withdrawal
Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism
Lentivirus‑mediated RNA interference targeting EBNA1 gene inhibits the growth of GT‑38 cells in vitro and in vivo
Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity